| Literature DB >> 23011275 |
Abstract
A petroleum ether extract (PEE) and a methanolic extract (ME) of aerial parts of Salvia bicolor Desf were prepared, and their chemical compositions and antioxidant, anti-inflammatory, analgesic and antimicrobial activities were evaluated. GC/MS analysis of the PEE revealed the presence of 20 compounds in the unsaponifiable matter, among which β-sitosterol and β-amyrin (constituting 24.75% and 15.62%, respectively) were the main constituents, and 21 fatty acids, with linolenic acid and erucic acid being the main fatty acid constituents (21.65% and 16.65%, respectively). HPLC/MS analysis of the methanol extract for individual phenolics revealed the presence of 14 phenolic acids; protocatchuic acid was predominant (75.22 mg/g dry sample), followed by p-coumaric, gallic and synergic acids (70.27, 68.26 and 54.38 mg/g dry weight, respectively). HPLC/MS analysis of flavonoid contents revealed the presence of five flavonoid compounds, among which luteolin 7-O-glucoside and apigenin were the major constituents (120.25 mg/100 g dry sample and 88.48 mg/100g dry sample, respectively). The antioxidant activities of both extracts were evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, and the total antioxidant capacity was determined in terms of GAE (gallic acid equivalents). Anti-inflammatory and analgesic activities were evaluated using the rat paw edema and hot plate testing methods, respectively. The antimicrobial activities of both the PEE and ME were examined by means of the disk-diffusion method. The Salvia bicolor PEE and ME exhibited significant antioxidant, anti-inflammatory, and analgesic properties, in addition to antimicrobial effects against the selected microorganisms.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23011275 PMCID: PMC6268034 DOI: 10.3390/molecules171011315
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
GC/MS analysis of unsaponifiable matter in the S. bicolor PEE.
| Peak | Rt (min) | % | M+ | Base peak | Compound name |
|---|---|---|---|---|---|
| 1 | 18.99 | 0.50 | 156 | 57 | Undecane |
| 2 | 20.12 | 0.30 | 170 | 57 | Dodecane |
| 3 | 23.83 | 4.31 | 226 | 43 | Hexadecane |
| 4 | 26.7 | 1.40 | 240 | 57 | Heptadecane |
| 5 | 27.32 | 2.10 | 268 | 57 | Nonadecane |
| 6 | 28.9 | 2.13 | 282 | 57 | Eicosane |
| 7 | 30.7 | 7.70 | 296 | 57 | Heneicosane |
| 8 | 31.29 | 2.15 | 296 | 71 | Isophytol |
| 9 | 31.74 | 1.86 | 296 | 71 | Phytol |
| 10 | 32.10 | 2.50 | 310 | 57 | Docosane |
| 11 | 33.70 | 2.10 | 324 | 57 | Tricosane |
| 12 | 35.04 | 0.70 | 410 | 69 | Squalene |
| 13 | 36.20 | 10.10 | 366 | 57 | Hexacosane |
| 14 | 37.27 | 3.20 | 380 | 57 | Heptacosane |
| 15 | 38.80 | 11.01 | 394 | 57 | Octacosane |
| 16 | 39.80 | 0.70 | 400 | 43 | Campesterol |
| 17 | 40.30 | 2.40 | 412 | 55 | Stigmasterol |
| 18 | 41.04 | 24.75 | 414 | 43 | β-Sitosterol |
| 19 | 41.5 | 4.47 | 426 | 43 | Lupeol |
| 20 | 43.64 | 15.62 | 426 | 207 | β-amyrin |
GC/MS analysis of the fatty acid methyl esters in the S. bicolor PEE.
| Peak | Rt (min) | % | M+ | Base peak | Compound name |
|---|---|---|---|---|---|
| 1 | 3.24 | 1.7 | 130 | 74 | Methyl ester of caproic acid (C6:0) |
| 2 | 3.67 | 0.37 | 158 | 74 | Methyl ester of caprylic acid (C8:0) |
| 3 | 5.46 | 1.86 | 172 | 74 | Methyl ester of pelargonic acid (C9:0) |
| 4 | 5.87 | 1.22 | 200 | 74 | Methyl ester of undecylic acid (C11:0) |
| 5 | 6.30 | 0.94 | 214 | 74 | Methyl ester of lauric acid (C12:0) |
| 6 | 7.22 | 2.13 | 228 | 74 | Methyl ester of tridecylic acid (C13:0) |
| 7 | 8.56 | 7.8 | 242 | 74 | Methyl ester of myristic acid (C14:0) |
| 8 | 9.83 | 1.65 | 256 | 74 | Methyl ester of pentadecylic acid (C15:0) |
| 9 | 10.31 | 10.6 | 270 | 74 | Methyl ester of palmitic acid (C16:0) |
| 10 | 11.07 | 2.8 | 284 | 74 | Methyl ester of margaric acid (C17:0) |
| 11 | 11.68 | 1.85 | 298 | 74 | Methyl ester of stearic acid (C18:0) |
| 12 | 12.50 | 1.63 | 296 | 55 | Methyl ester of oleic acid (C18:1) |
| 13 | 14.88 | 0.38 | 294 | 67 | Methyl ester of linoleic (C18:2) |
| 14 | 16.28 | 21.65 | 292 | 79 | Methyl ester of linolenic acid (C18:3) |
| 15 | 18.2 | 12.85 | 326 | 74 | Methyl ester of arachidic acid (C20:0) |
| 16 | 20.58 | 0.43 | 340 | 74 | Methyl ester of heneicosylic acid (C21:0) |
| 17 | 22.67 | 2.7 | 354 | 74 | Methyl ester of behenic acid (C22:0) |
| 18 | 24.32 | 16.65 | 352 | 55 | Methyl ester of erucic acid (C22:1) |
| 19 | 26.11 | 1.55 | 350 | 67 | Methyl ester of docosadienoic acid (C22:2) |
| 20 | 27.56 | 6.33 | 368 | 74 | Methyl ester of tricosylic acid (C23:0) |
| 21 | 28.53 | 2.91 | 382 | 74 | Methyl ester of lignoceric acid (C24:0) |
Phenolic acid content of the methanolic extract from the aerial parts of S. bicolor.
| Peak | Rt (min) | Concentration (mg/g dry sample) | Compound name |
|---|---|---|---|
| 1 | 2.3 | 68.26 ± 1.03 | Gallic acid |
| 2 | 2.8 | 25.44 ± 0.78 | Sinapic acid |
| 3 | 4.8 | 3.48 ± 0.83 | Caffeic acid |
| 4 | 6.3 | 0.72 ± 1.02 | Ferulic acid |
| 5 | 8.1 | 0.42 ± 1.65 | |
| 6 | 9.3 | 0.78 ± 0.45 | |
| 7 | 10.8 | 70.27 ± 0.74 | |
| 8 | 11.9 | 75.22 ± 1.41 | Protocatchuic acid |
| 9 | 12.2 | 1.44 ± 1.85 | |
| 10 | 13.5 | 0.53 ± 1.06 | Chlorogenic acid |
| 11 | 15.7 | 0.50 ± 0.92 | Gentisic acid |
| 12 | 20.9 | 54.38 ± 1.26 | Syringic acid |
| 13 | 21.5 | 0.68 ± 1.73 | |
| 14 | 22.0 | 0.45 ± 0.65 | Salicylic acid |
Notes: Values are the mean ± SD (n = 3).
Flavonoid content of the methanolic extract from aerial parts of S. bicolor.
| Peak | Rt (min) | Concentration (mg/100 g dry sample) | Mass Fragments (m/z) | Compound name |
|---|---|---|---|---|
| 1 | 23.2 | 120.25 ± 0.35 | 287, 285 | Luteolin-7-
|
| 2 | 40.8 | 54.96 ± 1.18 | 328, 313, 299, 285, 282, 153 | Salvigenin |
| 3 | 47.3 | 52.34 ± 0.97 | 273, 257, 179, 151 | Quercetin |
| 4 | 64.2 | 42.30 ± 0.56 | 267, 243, 241, 217, 151, 107 | Luteolin |
| 5 | 87.4 | 88.48 ± 1.32 | 269 | Apigenin |
Notes: Values are the mean ± SD (n = 3).
Figure 1DPPH radical-scavenging activity of the PEE and ME from aerial parts of S. bicolor relative to standard gallic acid.
Anti-inflammatory effect of the PEE and ME from S. bicolor aerial parts on carrageenan-induced rat paw edema.
| Group | After 1 h | After 2 h | After 3 h | After 4 h | ||||
|---|---|---|---|---|---|---|---|---|
| Edema (mm) | % inhibition | Edema (mm) | % inhibition | Edema (mm) | % inhibition | Edema (mm) | % inhibition | |
| Control (saline) | 78.2 ± 0.5 | -- | 95 ± 0.6 | ---- | 110 ± 0.6 | --- | 113 ± 0.7 | --- |
| PEE a | 70.5 ± 1.3 | 9.8 ± 1.5 | 77.8 ± 2.1 | 18.1 ± 1.6 | 84.5 ± 1.7 | 23.2 ± 2.9 | 80.3 ± 1.7 | 28.9 ± 1.8 |
| ME a | 60.2 ± 0.20 | 23 ± 0.22 | 77.8 ± 2.0 | 18.1 ± 2.07 | 77.65 ± 0.7 | 29.4 ± 2.7 | 73 ± 0.6 | 35.4 ± 1.4 |
| Indomethacinb | 70.1 ± 1.5 | 10.4 ± 1.3 | 77.0 ± 0.5 | 18.9 ± 0.20 | 75 ± 1.6 | 31.2 ± 1.7 | 75 ± 0.6 | 33.6 ± 1.2 |
Data are presented as the mean of three experiments ± SD; % inhibition was calculated as significant changes from control values at each respective time. a Dose: 50 mg/kg b. wt. b Dose: 10 mg/kg b. wt.
Analgesic effect of the PEE and ME from S. bicolor aerial parts determined via a hot plate test.
| Group | Pre-drug treatment | After 1 h | After 2 h | ||
|---|---|---|---|---|---|
| M ± SD | M ± SD | % of change | M ± SD | % change | |
| Control saline | 20 ± 0.97 | 21.85 ± 0.21 | -- | 20.85 ± 2.1 | --- |
| PEE a | 20.68 ± 0.47 | 27.85 ± 0.86 | 34.7 ± 1.3 | 32.6 ± 2.1 | 57.6 ± 1.6 |
| ME a | 19.33 ± 2.4 | 30.85 ± 0.49 | 59.6 ± 1.67 | 32.48 ± 2.2 | 68 ± 1.5 |
| Indomethacin b | 18.33 ± 0.69 | 23.5 ± 1.66 | 28.2 ± 1.66 | 28.9 ± 1.4 | 57.7 ± 1.2 |
M ± SD: mean of three experiments ± standard deviation; % change: calculated as significant changes from pre-drug treatment values. a Dose: 50 mg/kg b. wt. b Dose: 10 mg/kg b. wt.
Antimicrobial activity and MIC of the PEE and ME from S. bicolor determined using agar disc diffusion and MIC methods.
| Microorganism | PEE | ME | MICs of the standards | |||
|---|---|---|---|---|---|---|
| DD a M ± S.D. | MIC b | DD a M ± S.D. | MIC b | Gentamycin | Amphotericin B | |
|
| 13.2 ± 0.44 | 550 | 18.3 ± 0.92 | 200 | 8 × 10−3 | NT |
|
| 14.6 ± 1.17 | 650 | 16.8 ± 1.27 | 350 | 1 × 10−2 | NT |
|
| 10.7 ± 0.56 | 1,000 | 14.3 ± 0.64 | 350 | 8 × 10−3 | NT |
|
| 9.1 ± 0.24 | 1,000 | 12.7 ± 1.84 | 400 | 8 × 10−3 | NT |
|
| 7.2 ± 1.76 | 1,000 | 9.58 ± 1.26 | 1000 | 1 × 10−2 | NT |
|
| 8.8 ± 0.77 | 1,000 | 9.3 ± 0.60 | 1000 | 1 × 10−2 | NT |
|
| 11.4 ± 0.54 | 900 | 11.4 ± 0.70 | 400 | 1 × 10−2 | NT |
|
| 10.2 ± 1.28 | 1,000 | 13.6 ± 0.62 | 400 | 1 × 10−2 | NT |
|
| 13.2 ± 0.43 | 400 | 16.4 ± 1.30 | 350 | NT | 1 × 10−3 |
|
| 7.2 ± 0.76 | 1,000 | 7.3 ± 1.40 | 1000 | NT | 1 × 10−3 |
|
| 8.2 ± 0.93 | 1,000 | 8.5 ± 1.87 | 1000 | NT | 1 × 10−3 |
|
| 8.5 ± 0.36 | 1,000 | 8.5 ± 0.85 | 1000 | NT | 1 × 10−3 |
a DD, agar disc diffusion method. Diameter of the inhibition zone (mm) including the disc diameter of 6 mm; b MIC, minimum inhibitory concentration; values are given as µg/mL; NT, not tested; M ± S.D., mean of three experiments ± standard deviation.